Journal
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY
Volume 50, Issue 2, Pages 79-89Publisher
JAPANESE SOC LYMPHORETICULAR TISSUE RESEARCH
DOI: 10.3960/jslrt.50.79
Keywords
mesenchymal stromal cells; bone marrow; immunosuppression; graft-versus-host disease
Categories
Ask authors/readers for more resources
Mesenchymal stromal cells (MSCs) have unique characteristics such immune suppression by inhibitingT cell proliferation, tissue-repair ability and acceleration of hemopoietic stem cell engraftment. The cells are rare in bone marrow, but easily cultured under standard culture conditions. Soluble factors and cells are implicated in the MSC-mediated T cell suppression and numerous clinical trials using MSCs to prevent and treat graft-versus-host disease (GVHD) have been reported. MSCs are suggested to suppress acute GVHD without impairing graft-versus-leukemia effects and increasing systemic infections. In this review, we focus on basic aspects of MSC-mediated T cell suppression and clinical trials using MSCs for GVHD and related conditions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available